David Antoniucci: Clinical Trials

3 trials sponsored by David Antoniucci, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1
Phase 31Completed 1

Follow David Antoniucci: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mojito Study (Mashed Or Just Integral Pill of TicagrelOr ? )
Ticagrelor mashed pills, Ticagrelor integral pills - Acute Coronary Syndrome, Adverse Reaction to Antiplatelet Agent
Phase 3CompletedDavid Antoniucci822013-11-012015-03-17
Rapid Activity of Platelet Inhibitor Drugs Study 2
Prasugrel, Ticagrelor - Myocardial Infarction
Phase 4CompletedDavid Antoniucci502012-11-012014-09-25
BLeeding Events and Maintenance DoSe of PraSugrel
Prasugrel dose 5 mg/day, Prasugrel dose 10 mg/day - Adverse Reaction to Antiplatelet Agent, Acute Coronary Syndrome
Phase 4TerminatedDavid Antoniucci1952012-11-012016-07-29

Conditions studied

Acute Coronary Syndrome (2)  ·  Myocardial Infarction (1)

Interventions

Prasugrel Hydrochloride (1)  ·  Ticagrelor (1)

Countries

Italy (3)  ·  Greece (1)

Top investigators

Guido Parodi, MD (1)

Results publications

PMID 24890542, PMID 27843564